Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

5 of 5 completed trials have results

Key Signals

5 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04333433Completed

PRESERFLO® MicroShunt Extension Study

Role: lead

NCT01881425Not ApplicableCompleted

InnFocus MicroShunt Versus Trabeculectomy Study

Role: lead

NCT00772330Not ApplicableCompleted

Clinical Study of the Safety and Performance of the Miami InnFocus Drainage Implant to Relieve Glaucoma Symptoms

Role: lead

NCT02177123Not ApplicableCompleted

Post Market Study of the InnFocus MicroShunt

Role: lead

NCT01563237Not ApplicableCompleted

Safety and Performance of Miami InnFocus Drainage Implant (MIDI Arrow) Glaucoma Drainage Implant

Role: lead

All 5 trials loaded